Akumin Inc. is a leading provider of diagnostic imaging services in the United States, with operations in over 100 locations across the country. The company is based in Boca Raton, Florida, and was founded in 2015.
Akumin's primary business segments include the provision of diagnostic imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. The company focuses on providing high-quality, affordable imaging services to patients and healthcare providers throughout the United States.
One of the key strengths of Akumin is their focus on technology and innovation. The company invests heavily in research and development, with a focus on developing new and improved diagnostic imaging technologies that can improve patient outcomes and increase efficiency. This approach has allowed Akumin to stay at the forefront of the rapidly-evolving healthcare industry.
In addition to their focus on technology and innovation, Akumin also places a strong emphasis on patient care. The company is committed to providing patients with a high-quality, personalized experience, with a focus on patient comfort and safety. This commitment to patient care has earned Akumin a reputation as a trusted and reliable provider of diagnostic imaging services.
Financially, Akumin has a strong track record of growth and profitability. The company reported revenue of $379 million in 2020, representing an increase of 10.2% over the previous year. Net income for the same period was $3.3 million, compared to a net loss of $56 million in the previous year.
Akumin's stock is publicly traded on the NASDAQ stock exchange under the ticker symbol AKU. The company has a market capitalization of approximately $330 million as of September 2021.
Akumin Inc. is a leading provider of diagnostic imaging services in the United States, with a strong focus on technology, innovation, and patient care. The company's commitment to research and development, patient care, and strong financial performance make them an attractive partner for patients, healthcare providers, and investors seeking exposure to the healthcare industry. With their extensive experience and investment in R&D, Akumin is well-positioned to continue to develop innovative solutions that can improve patient outcomes and drive growth in the years ahead.